You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Identify and Act: Lipodystrophy for Nonspecialists

  • Authors: Elif Arioglu Oral, MD; David Araújo-Vilar, MD, PhD; Abhimanyu Garg, MD; David Savage, MD 
  • CPD Released: 5/24/2022
  • Valid for credit through: 5/24/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.75 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for diabetologists & endocrinologists, pediatricians, and internal medicine specialists.

The goal of this activity is that learners will be better able to recognize, diagnose, and refer patients with LD syndromes to specialist centers for management and follow-up.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Burden of LD
    • The importance of referring patients as early as possible to specialist centers
  • Have greater competence related to
    • Diagnosing LD


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.    

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.  

Disclosures for additional planners can be found here.


Moderator

  • Elif Arioglu Oral, MD

    Professor of Internal Medicine 
    Division of Metabolism, Endocrinology and Diabetes 
    Department of Internal Medicine 
    University of Michigan Medical School 
    Ann Arbor, Michigan, United States 

    Disclosures

    Disclosure: Elif Arioglu Oral, MD, has the following relevant financial relationships:
    Consultant or advisor for: Amryt Pharma Plc; Ionis Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Third Rock Ventures
    Research funding from: Amryt Pharma Plc
    Contracted researcher for: Amryt Pharma Plc; Dactyl; GI Dynamics; Ionis Pharmaceuticals; Novo Nordisk; Regeneron Pharmaceuticals, Inc
    Patent beneficiary of: Metreleptin owned by Amryt Pharma Plc

Faculty

  • David Araújo-Vilar, MD, PhD

    Associate Professor and Leader
    Lipodystrophies Lab UETeM
    Molecular Pathology of Rare Diseases Group
    Department of Psychiatry, Radiology, Public Health, Nursing and Medicine
    IDIS-CiMUS
    University of Santiago de Compostela
    Division of Endocrinology and Nutrition
    University Clinical Hospital of Santiago de Compostela
    Santiago de Compostela, Spain

    Disclosures

    Disclosure: David Araújo-Vilar, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Amryt Pharma Plc
    Speaker or member of speakers bureau for: Amryt Pharma Plc 
    Research funding from: Aegerion Pharmaceuticals, Inc

  • Abhimanyu Garg, MD

    Chief 
    Division of Nutrition and Metabolic Diseases 
    Department of Internal Medicine and the Center for Human Nutrition 
    UT Southwestern Medical Center 
    Dallas, Texas, United States 

    Disclosures

    Disclosure: Abhimanyu Garg, MD, has the following relevant financial relationships:
    Consultant or advisor for: Amryt Pharma Plc; Health Advances; Kyttaro Limited; Regeneron Pharmaceuticals, Inc.; Third Rock Ventures
    Research funding from: Amryt Pharma Plc; Ionis Pharmaceuticals; Quintiles/Measure; Regeneron Pharmaceuticals, Inc
    Stock options from: Kyttaro Limited

  • David Savage, MD

    Professor and Wellcome Trust Senior Clinical Fellow
    Metabolic Research Laboratories
    Wellcome Trust-Medical Research Council Institute of Metabolic Science
    University of Cambridge
    Cambridge, United Kingdom

    Disclosures

    Disclosure: David Savage, MD, has no relevant financial relationships.

Editor

  • Rita Moreira Da Silva, PhD, PharmD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Rita Moreira Da Silva, PhD, PharmD, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Susan L. Smith, MN, PhD, has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.75 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Identify and Act: Lipodystrophy for Nonspecialists

Authors: Elif Arioglu Oral, MD; David Araújo-Vilar, MD, PhD; Abhimanyu Garg, MD; David Savage, MD Faculty and Disclosures

CPD Released: 5/24/2022

Valid for credit through: 5/24/2023

processing....

Contents of This CPD Activity

All sections of this activity are required for credit.

What Is Lipodystrophy, the Natural History, and Burden of This Disease?   

Learn more about the epidemiology and pathophysiology of this rare condition.
Elif Arioglu Oral, MD

Diagnosing Lipodystrophy: Overcoming the Challenges

How prepared are you to identify and diagnose lipodystrophy (LD) syndromes?
Elif Arioglu Oral, MD

A Case Review of Recognition and Diagnosis

Go from theory to practice with a walk-through description of a real patient with LD.
Abhimanyu Garg, MD

Management of Lipodystrophy: The Role of Leptin Replacement Therapy

As an important hormone in the pathophysiology of LD, learn here how leptin determines its management.
David Araújo-Vilar, MD, PhD

Act by Referring to Specialist Centers

Timely referral is key to optimize management of patients with LD: the experience of the United Kingdom.
David Savage, MD